Skip to main content
Atrás
Watch Compare

Minerva Neurosciences, Inc.

Calidad de datos: 83%
NERV
Nasdaq Manufacturing Chemicals
$5.51
▼ $0.51 (-8.47%)
Cap. Mercado: 239.96 M
Precio
$5.55
Cap. Mercado
239.96 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Earnings declined -20492.68% over the past year
Negative free cash flow of -13.51 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-20492.68%
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROIC-44.76%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio4.87
Interest CoverageN/A

Valoración

PE (TTM)
-0.82
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1366 pares)
Métrica Acción Mediana del Sector
P/E -0.8 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

2 analistas
Hold
Actual
$5.51
+31.6%
Objetivo
$7.25
$7.00
$7.25
$7.50
Pronóstico
P/E Futuro -11.48
EPS Futuro -$0.48
Ingresos Est. 0.0

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$0.48
-$0.48 – -$0.48
 0.0 1
FY2026 -$0.60
-$0.60 – -$0.60
 0.0 1

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.11 -$0.64 -481.8%
Q32025 N/A -$0.36 —
Q22025 -$0.90 -$0.43 +52.2%
Q12025 -$1.07 -$0.50 +53.3%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) -20492.68% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -293.42 M
ROE N/A ROA -1002.96%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -13.51 M
ROIC -44.76% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.87
Interest Coverage N/A Asset Turnover N/A
Working Capital 10.35 M Tangible Book Value -49.45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.82 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -5.63%
Market Cap 239.96 M Enterprise Value 227.67 M
Per Share
EPS (Diluted TTM) -34.67 Revenue / Share N/A
FCF / Share -0.31 OCF / Share -0.31
EPS CAGR (1Y) -18347.37% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 4.60%
SBC-Adj. FCF -14.69 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — 0.0 0.0 0.0 41.18 M
Net Income -293.42 M 1.44 M -30.01 M -32.11 M -49.91 M
EPS (Diluted) -34.67 0.19 -4.61 -6.01 -1.17
Gross Profit — — — — —
Operating Income -15.10 M -21.85 M -23.12 M -25.23 M -45.37 M
EBITDA — — — — —
R&D Expenses 5.76 M 11.90 M 12.71 M 14.65 M 32.04 M
SG&A Expenses — — — — —
D&A 5,442.0 5,442.0 5,442.0 — 16,011.0
Interest Expense — — — — —
Income Tax — — — -1.80 M -1.80 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 97.97 M 37.14 M 56.90 M 55.09 M 77.12 M
Total Liabilities 233.76 M 62.84 M 85.36 M 75.11 M 69.15 M
Shareholders' Equity -140.75 M -25.69 M -28.46 M -20.02 M 7.98 M
Total Debt — — — — —
Cash & Equivalents 82.30 M 21.36 M 40.91 M 36.09 M 60.76 M
Current Assets 83.10 M 22.27 M 42.00 M 40.16 M 62.20 M
Current Liabilities 2.29 M 2.84 M 3.34 M 1.38 M 2.82 M